FDA Approves Abbott's Xience Prime Drug-Eluting Stent
Abbott announced today that it had received FDA approval for its Xience Prime everolimus-eluting stent. The cobalt chromium stent is designed to be delivered more easily to complex lesions and will be available in long lengths up to 38 mm. ...
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug ...
FDA approves new coronary and iliac stents
Abbott wins FDA nod for Xience Prime stent